Antengene’s Xpovio Secures NMPA Approval for R/R Diffuse Large B-Cell Lymphoma
Antengene Corp., Ltd (HKG: 6996), a biopharmaceutical company based in China, has announced that it...
Sirnaomics’ STP122G Achieves Phase I Milestone with Positive Interim Data for Anticoagulation Treatment
Sirnaomics Ltd (HKG: 2257) has announced the completion of the Phase I second sequence for...
Kindstar Global and MGI Tech Co., Ltd. Form Partnership to Establish Multi-Omics Service Center in China
Kindstar Global (HKG: 9960), a biopharmaceutical company based in China, has announced a strategic partnership...
Pharmaceutical Giants Face UK Industry Code Breach Allegations, Including Novartis and Pfizer
Several multinational pharmaceutical corporations have been reprimanded for violating the UK’s Prescription Medicines Code, a...
Roche’s Tiragolumab Misses Primary Endpoints in NSCLC Trial, Study Halted
Roche (SWX: ROG; SWX: RO; OTCMKTS: RHHBY), the Swiss pharmaceutical giant, has announced that a...
Medigene AG Secures Chinese Patent for TCR-T Therapy Targeting NY-ESO-1 and LAGE 1a
Medigene AG (ETR: MDG1), a biopharmaceutical company based in Germany, has announced that it has...
MicroPort Scientific Corp’s Subsidiaries Forecast Significant H1 2024 Revenue Growth
MicroPort Scientific Corp (HKG: 0853), a leading medical device company, has seen its subsidiaries Shanghai...
Singlera Genomics Secures Over RMB 100 Million in Strategic Financing to Boost R&D and Commercialization
Singlera Genomics Inc., a genetic testing and molecular diagnostics company with operations in San Diego,...
Doma Biopharmaceutical’s Bispecific ADC DM001 Receives FDA Clearance for Clinical Trial
Doma Biopharmaceutical (Suzhou) Co., Ltd, a biopharmaceutical company based in China, has announced that it...
Jiangsu Hengrui Pharmaceuticals Gets NMPA Green Light for HRS-9813 IPF Clinical Trial
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company in China, has announced...
Luye Pharma’s Oxycodone/Naloxone Product Receives NMPA Approval for Severe Pain Management
Luye Pharma Group (HKG: 2186), a pharmaceutical company based in China, has announced that it...
Semaglutide Use Linked to Rare Eye Condition NAION in New Study
A recent study has identified a potential link between the use of GLP-1-targeted diabetes and...
J&J’s Rybrevant Earns First-Line NSCLC Approval in Canada, a Milestone for EGFR Exon 20 Patients
Johnson & Johnson (J&J; NYSE: JNJ) has announced that Rybrevant (amivantamab) has received its first...
Sanofi’s RSV Preventative Therapy Beyfortus Launches in China
Sanofi (NASDAQ: SNY), a leading French pharmaceutical company, has announced the commercial launch of Beyfortus...
Genertec and CTHG Fund Invest in Neusoft Medical Systems to Boost Medical Imaging
China General Technology (Group) Holding Co Ltd, commonly referred to as Genertec, has announced plans...
Guangzhou Pluslife Partners with Gates Foundation to Combat STIs in Low-Income Countries
Guangzhou Pluslife Technology Co., Ltd, a specialist in Point-Of-Care Testing (POCT) based in China, has...
United Imaging Healthcare to Launch Financial Leasing Arm with RMB 450 Million Investment
United Imaging Healthcare (UIH, SHA: 688271), a leading medical equipment company based in Shanghai, has...
Ascentage Pharma Receives USD 100 Million Option Rights Payment from Takeda
Ascentage Pharma (HKG: 6855), a biopharmaceutical company based in China, has announced that it has...
Full-Life Technologies’ ²²⁵Ac-FL-020 Earns FDA Fast-Track Status for mCRPC
Full-Life Technologies Ltd, a globally integrated radiotherapeutics company with a presence in Belgium, Germany, and...
HutchMed’s Tazverik for Follicular Lymphoma Accepted for Review by China’s NMPA
HutchMed (NASDAQ: HCM), a China-based biopharmaceutical company, has announced that the National Medical Products Administration...